Outlook Therapeutics, Inc.
OTLK
$0.64
$0.000.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.24M | 7.75M | 8.68M | 8.08M | 8.90M |
| Total Receivables | 1.64M | 2.72M | 114.60K | 1.49M | 1.75M |
| Inventory | 5.04M | 3.34M | 3.46M | 3.34M | 4.13M |
| Prepaid Expenses | 5.24M | 7.09M | 4.92M | 4.48M | 6.32M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.17M | 20.90M | 17.17M | 17.39M | 21.10M |
|
|
|||||
| Total Current Assets | 23.17M | 20.90M | 17.17M | 17.39M | 21.10M |
| Net Property, Plant & Equipment | 185.20K | 199.00K | 212.40K | 225.50K | 238.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 304.00K | 320.30K | 346.10K | 417.50K | 464.40K |
| Total Assets | 26.18M | 21.89M | 18.24M | 18.58M | 22.39M |
|
|
|||||
| Total Accounts Payable | 6.81M | 13.64M | 7.32M | 10.19M | 10.26M |
| Total Accrued Expenses | 3.28M | 9.04M | 4.71M | 5.31M | 5.31M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.29M | 15.91M | 36.72M | 30.01M | 14.06M |
| Total Finance Division Other Current Liabilities | 302.00K | 302.00K | 302.00K | 302.00K | 1.86M |
| Total Other Current Liabilities | 302.00K | 302.00K | 302.00K | 302.00K | 1.86M |
| Total Current Liabilities | 28.68M | 38.88M | 49.06M | 45.81M | 31.49M |
|
|
|||||
| Total Current Liabilities | 28.68M | 38.88M | 49.06M | 45.81M | 31.49M |
| Long-Term Debt | -- | 11.12M | -- | -- | 20.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 140.10K | 157.00K | 172.00K | 188.80K | 204.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.76M | 722.20K | 7.56M | 4.77M | 7.45M |
| Total Liabilities | 36.58M | 50.89M | 56.79M | 50.77M | 59.58M |
|
|
|||||
| Common Stock & APIC | 643.15M | 604.23M | 590.22M | 573.52M | 555.23M |
| Retained Earnings | -653.54M | -633.22M | -628.77M | -605.71M | -592.42M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -10.39M | -28.99M | -38.55M | -32.19M | -37.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.39M | -28.99M | -38.55M | -32.19M | -37.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.39M | -28.99M | -38.55M | -32.19M | -37.19M |
|
|
|||||